Plasma interleukin-6 levels in Mediterranean spotted fever
J. Oristrell(Corporació Sanitària Parc Taulí), F. Segura(Hospital Privado), Bernat Font(Barcelona Supercomputing Center), María José Amengual, Moga Sampere(Corporació Sanitària Parc Taulí)
European Journal of Clinical Microbiology & Infectious Diseases
April 21, 2004
Cited by 8
Related Papers
Predictive Factors for Invasive Disease Due to Penicillin-Resistant Streptococcus pneumoniae: A Population-Based Study
|Clinical Infectious Diseases|1994|219
Clinical and Laboratory Characteristics of 144 Patients with Mediterranean Spotted Fever
|European Journal of Clinical Microbiology & Infectious Diseases|2003|212
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study
|The Lancet HIV|2020|70
Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever
|Antimicrobial Agents and Chemotherapy|1990|56